Common insecticides have been linked in studies to neurodevelopmental disorders.

Published Date: 26 Apr 2023

According to a recent study from The University of Toledo, even at levels that are currently recognized, early exposure to the common class of insecticides known as pyrethroids may increase the risk of autism and other developmental disorders.

Read Full News

Latest News

‘Good First Try’: In Vivo CAR T for Neuro Autoimmune Disease

A single infusion of an off-the-shelf lentiviral vector generates CAR T cells inside patients with refractory neurologic autoimmune disease. But do the results go beyond existing therapies?

Which Therapies Offer the Lowest Relapse Rates in Early MS?

Patients with MS starting B-cell therapies had fewer relapses and less T2 lesion growth, but no measurable difference in disability after 2 years.

AbbVie's Menstrual Migraine Treatment Meets Late-stage Study Goal

AbbVie said on Thursday its migraine treatment had in ⁠a late-stage study reduced the migraine days associated with the ⁠menstrual period.

US FDA Pauses New Enrollment in Biohaven's Epilepsy Drug Trials

Biohaven said on Thursday the U.S. FDA had imposed a partial clinical hold, pausing new patient enrollment in trials ⁠of its experimental epilepsy drug after rodent...

Tylenol Use in Pregnancy May Be Linked With Uterus, Ovary Changes in Daughters

Female reproductive organ development may be impacted by a mother's use during pregnancy of Tylenol or its generic versions, according to researchers who emphasize that...

Ionis Pharma Prices First FDA-approved Treatment for Alexander Disease At $285,000 Per Dose

Ionis Pharmaceuticals said on Friday it would price its newly approved therapy ⁠to treat Alexander disease at $285,000 per dose, a day after the U.S. FDA cleared the...

Todays Updates

First-Line Combo Therapies Best Chemo Alone in NSCLC Trials

New phase 3 data add to a growing number of EGFR-directed first-line options for advanced NSCLC with EGFR exon 20 insertions.

3D Mammography Improves Long-Term Cancer Risk Prediction

Researchers develop and validate a deep learning model using longitudinal 3D tomosynthesis examinations to predict individualized 5-year risk for breast cancer.

Todays Updates

First-Line Combo Therapies Best Chemo Alone in NSCLC Trials

New phase 3 data add to a growing number of EGFR-directed first-line options for advanced NSCLC with EGFR exon 20 insertions.

3D Mammography Improves Long-Term Cancer Risk Prediction

Researchers develop and validate a deep learning model using longitudinal 3D tomosynthesis examinations to predict individualized 5-year risk for breast cancer.

Latest News

A single infusion of an off-the-shelf lentiviral vector generates CAR T cells inside patients with refractory neurologic autoimmune disease. But do the results go beyond existing therapies?

Patients with MS starting B-cell therapies had fewer relapses and less T2 lesion growth, but no measurable difference in disability after 2 years.

AbbVie said on Thursday its migraine treatment had in ⁠a late-stage study reduced the migraine days associated with the ⁠menstrual period.

Biohaven said on Thursday the U.S. FDA had imposed a partial clinical hold, pausing new patient enrollment in trials ⁠of its experimental epilepsy drug after rodent...

Female reproductive organ development may be impacted by a mother's use during pregnancy of Tylenol or its generic versions, according to researchers who emphasize that...

Ionis Pharmaceuticals said on Friday it would price its newly approved therapy ⁠to treat Alexander disease at $285,000 per dose, a day after the U.S. FDA cleared the...

News All Time

What New Research Shows About Prenatal Pesticide Exposure and Autism Traits

— Chlorpyrifos and other organophosphate insecticides had no association at low exposure levels

Young Girl Dies From Rare Brain-Eating Amoeba

Louisiana experienced its first confirmed Naegleria fowleri infection since 2013

The New Standard in Multiple Sclerosis: Integrating Evolving Treatment Evidence and Biomarkers to Target Progression

The New Standard in Multiple Sclerosis: Integrating Evolving Treatment Evidence and Biomarkers to Target Progression

Navigating Diagnostic Complexity in Leptomeningeal Metastases: Real-World Case Challenges in Timely Diagnosis of Leptomeningeal Metastases

Navigating Diagnostic Complexity in Leptomeningeal Metastases: Real-World Case Challenges in Timely Diagnosis of Leptomeningeal Metastases

Dravet Syndrome Clinical Pearls: Uncovering Disease Impact and Partnering With Patients and Caregivers to Individualize Treatment Plans

Dravet Syndrome Clinical Pearls: Uncovering Disease Impact and Partnering With Patients and Caregivers to Individualize Treatment Plans

Leptomeningeal Metastases: Early Recognition, Diagnosis, and Multidisciplinary Care

Leptomeningeal Metastases: Early Recognition, Diagnosis, and Multidisciplinary Care

Decoding Leptomeningeal Metastases: Strategies for Early Detection and Accurate Diagnosis

Decoding Leptomeningeal Metastases: Strategies for Early Detection and Accurate Diagnosis

Superagers' Exceptional Memory Can't Be Explained by Genes Alone, Study Finds

Inherited Alzheimer's risk didn't differ between superagers and cognitively average older adults

Diarrhea Bug Outbreak Hits 4 More States; Fauci to Testify; Doc Dies in House Fire

Health news and commentary gathered by MedPage Today staff

Hold Off on JAK Inhibitors in Rheumatoid Arthritis Until After Shingles Vax?

Good things come to those who wait -- and to those who don't wait

FDA Approves Tylenol With Naproxen Combination

First OTC fixed-dose combination product to pair acetaminophen with naproxen sodium

FDA Panel Finds a Peptide It Doesn't Like

Over 2-day meeting, six of seven peptides are recommended for adding to bulk compounding list

Brain Worm Culprit in Woman's Hallucinations, Incoherent Speech

MRI uncovers neurocysticercosis in a 52-year-old woman

First-in-Class Drug for ADHD Wins FDA Approval

Triple reuptake inhibitor centanafadine is indicated for patients ages 6 years and older

FDA Scientists Raise Questions About Duchenne Drug

Agency says deramiocel did not meet phase III trial endpoints, contrary to reported data

Feds Delay Autism Meeting; Wildfire Smoke and Migraine; Mortality and MS

News and commentary from the world of neurology and neuroscience

Recommended News For You

Do I qualify for a cancer clinical trial?

FDA Approves New Bladder Cancer First-Line Standard of Care.

Long-Acting Interferon Therapy Approved for ET

Except for Black Patients, the Rates of Gallbladder Cancer Are Stable or Declining.

Advances in "next generation" photoactive cancer therapy

Potential new therapy for childhood brain cancer could heal treatment-resistant tumors

Research has shown that Ga-68 FAPI PET enhances pancreatic cancer detection and staging.

Recommended Articles For You

Tertiary Lymphoid Structures: Pivotal Players in Cancer Prognosis and Therapeutic Response 

Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025 

Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy  

Rehabilitation Through Prehabilitation Before Complex Cancer Surgery 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New target points to combination therapy for thwarting multidrug resistance in cancer treatment

2.

Research identifies nearly 200 potential breast carcinogens in food packaging materials

3.

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

4.

AI is useful in low-resource areas for triaging breast masses.

5.

Chemotherapy can be a challenging treatment?here's how to deal with some of the side-effects

1.

Hematopoietic Stem Cell Activity Biomarkers in Aging

2.

Beating Cancer Fatigue The Most Effective Exercise Strategies for Breast Cancer Survivors

3.

Functional Genomics of Treatment-Resistant Anemia

4.

Modern Applications in Oncology in the Digital Era

5.

Understanding Vaso Occlusive Crisis: Symptoms, Causes, and Management Strategies

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men

2.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

3.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

4.

Lung Cancer: Risk Factors and Prevention

5.

Latest Advances in Hematology

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot